Gender Differences in Takotsubo Syndrome

Published Date: 14 Mar 2023

Takotsubo syndrome is more common in women. Less is known about its occurrence in men. This study provides a description of the disease characteristics and incidence of TTTS in men.

Read Full News

Latest News

Study Identifies Novel Stress-Inflammation Pathway in AD

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

Scotland Backs New Immunotherapy in Advanced Cervical Cancer

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Eye Shingles Tied to Cancer Risk in Those With Immune Issues

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

SLIT Adherence May Lower Rhinitis Severity in Children

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

Novo Nordisk Weight-loss Drug Shows Liver Benefits in Mouse Study

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Schistosomiasis: Four Things You May Not Know

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

News All Time

Replimune's Drug for Advanced Skin Cancer Fails to Win FDA Nod Again

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Most US Infants Have an Enteric Viral Infection by Age 2

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Conference MDAngle: AAN 2026 Myasthenia Gravis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

Neuroimmunome Predicts Viral Hepatitis Severity

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Potato Allergy in Children: New Data

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

‘Unchartered Territory’: CAR T Results in Ped Rheumatology

Among the challenges of conducting larger clinical trials is identifying appropriate patient populations.

Consider Kids’ Sports Gear as a Source of Contact Dermatitis

Modifications and alternative products can help manage sports-related allergens in children with allergic contact dermatitis.

Minority Families Describe Barriers to Pediatric Derm Care

Racially and ethnically minoritized communities perceive multiple barriers in accessing pediatric dermatology care, a study shows.

Recombinant Flu Shot Boosts Early Immune Response in Obesity

In patients with severe obesity, the recombinant influenza vaccine yields stronger short-term antibody responses than the egg-based standard-dose vaccine, with no safety concerns noted.

Glycoprotein Acetyls May Serve as a Biomarker for Psoriasis

Glycoprotein acetyls and phenylalanine are associated with psoriasis and joint involvement in the case of psoriatic arthritis, respectively, a cross-sectional study reveals.

Low Iodine Tied to Mortality in Women Post-Kidney Transplant

Lower dietary iodine intake is significantly associated with an increased risk for mortality in female, but not male, kidney transplant recipients, indicating a potential sex-specific vulnerability.

Real-World Data Show Avacopan Safety Signals in Vasculitis

Avacopan shows a favorable safety profile in ANCA-associated vasculitis in real-world settings, with hepatobiliary events as the leading safety concern and no adverse events of high clinical priority.

Paper Products Don’t Provoke Formaldehyde Reactions

Testing of various paper products available in the US yielded reassuring results.

Flu Vaccine Cuts Kids’ Hospitalization Risk by Up To 60%

The vaccine is 43% effective in reducing hospitalizations and medical visits due to influenza A (H3N2).

Safety of Tofacitinib vs Biologics in PsA: One Risk Differs

Tofacitinib shows safety comparable with biologics for PsA regarding serious infections, myocardial infarction or stroke, and malignancy but is tied to a higher risk for VTE than TNF inhibitors.

Early Oral Antibiotics: A Safe Shift in Bone Infections

Early switching from intravenous to oral treatment does not compromise treatment success in children with bone and joint infections and may reduce the risk for complications.

Recommended News For You

More People Than Previously Believed Have Schizophrenia.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Study finds higher breast cancer rates in areas with more air pollution

New imaging guidelines for head and neck cancers, a step toward practice change

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

Recommended Articles For You

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making 

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer 

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health 

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

5.

Microplastics can cause malignant changes in lung cells

1.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

2.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

3.

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management

4.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

5.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

Current Scenario of Cancer- The Incidence of Cancer in Men

4.

Navigating the Complexities of Ph Negative ALL - Part I

5.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot